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Abstract: Our purpose was to identify mutations responsible for non-syndromic congenital cataracts
through the implementation of next-generation sequencing (NGS) in our center. A sample of peripheral
blood was obtained from probands and willing family members and genomic DNA was extracted
from leukocytes. DNA was analyzed implementing a panel (OFTv2.1) including 39 known congenital
cataracts disease genes. 62 probands from 51 families were recruited. Pathogenic or likely pathogenic
variants were identified in 32 patients and 25 families; in 16 families (64%) these were de novo
mutations. The mutation detection rate was 49%. Almost all reported mutations were autosomal
dominant. Mutations in crystallin genes were found in 30% of the probands. Mutations in membrane
proteins were detected in seven families (two in GJA3 and five in GJA8). Mutations in LIM2 and MIP
were each found in three families. Other mutations detected affected EPHA2, PAX6, HSF4 and PITX3.
Variants classified as of unknown significance were found in 5 families (9.8%), affecting CRYBB3, LIM2,
EPHA2, ABCB6 and TDRD7. Mutations lead to different cataract phenotypes within the same family.
Keywords: congenital cataracts; genetics; next-generation sequencing; ophthalmogenetics
1. Introduction
The ocular lens is part of the anterior segment of the human eye. As part of the
refractive system, its main function is to transmit and focus light onto the retina due to
its transparency, shape and accommodative power [1–3]. Proteins represent up to 60%
of the lens mass, mostly as lens crystallins, whose distribution and stability are critical
for light transmission [4,5]. Any disturbance in the cell structure will produce diffraction,
absorbance or reflection of the light, which will result in diminished vision [6].
A cataract is an opacity of the lens [7]. Congenital or infantile cataracts present within
the first year of life and are considered to be the main cause of treatable blindness during
infancy worldwide. Reported incidence ranges from 12 to 136 per 100,000 births, with
higher rates in under-developed countries [8]. Congenital cataracts can be caused by
connatal infections, fetal suffering or genetic variations. It is estimated that 8.3–25% of
congenital cataracts are hereditary [9]; remarkably, they were the first autosomal disease
mapped in humans [10]. Hereditary cataracts can be divided into two groups: syndromic
cataracts, which form part of a systemic disease affecting other tissues, and non-syndromic
cataracts, in cases in which the lens is the only compromised organ. It is important to
understand that cataract phenotype is not a reliable indicator of the affected gene or
Genes 2021, 12, 580. https://doi.org/10.3390/genes12040580 https://www.mdpi.com/journal/genes
Genes 2021, 12, 580 2 of 13
mutation, since identical cataracts can be caused by mutations at different loci; the same
mutation can also cause different types of cataracts [10–15].
Currently, the only treatment for congenital cataracts is surgery, with the removal of
the opacified lens. Early intervention is crucial due to the high risk of amblyopia. Cataract
surgery in babies and infants has a high risk of postoperative complications and it is
a challenge to achieve a good visual acuity despite timely intervention and adequate
follow-up [16–20].
Mutations causing congenital cataracts affect the process of protein aggregation and
involve the breakdown of lens architecture. All three types of Mendelian inheritance
patterns have been reported, although the most frequent is autosomal dominant with
high penetrance. There may be remarkable phenotype variability within a family and
even between the two lenses of the same individual (Figure 1a polar cataract; Figure 1b
nuclear cataract). Mutations in over 52 genes have been described so far, 35 associated with
non-syndromic congenital cataracts and 17 which may cause either syndromic or isolated
cataracts. Mutations can be divided depending on the proteins affected into four main
groups: lens crystallins (37%), membrane proteins (22%), transcription factors (14%) and
cytoskeletal proteins (3–7%) [21–25].
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Figure 1. (a) Polar anterior congenital cataract; (b) uclear congenital cataract.
The purpose of this study is to identify the mutations leading to the development of
non-syndromic congenital cataracts in our hospital, which is one of the main referral centers
for the diagnosis and treatment of this pathology in Spain, through the implementation of
next-generation sequencing (NGS) for mutation screening.
2. Objectives
- To evaluate the implementation of NGS for mutation screening in congenital cataracts
at a tertiary hospital in Spain.
- To identify the mutations that produce congenital cataracts in Spain and compare
them with those reported for other populations.
3. Results
A total of 62 probands from 51 families diagnosed with non-syndromic congenital
cataracts were recruited. After performing NGS analysis with a specifically designed panel,
we identified pathogenic or likely pathogenic variants in 32 patients and 25 families: this
represents a mutation detection rate of 49% (Tables 1 and 2). Variants classified as a variant
of unknown significance (VUS) were found in seven patients and five families (9.8%).
Gender distribution was 35.5% of male and 64.5% of female probands. The majority of
families were from a Caucasian European background. The most frequent cataract pheno-
type was nuclear (55.3%), followed by lamellar (23.7%), posterior subcapsular (5.3%) and
posterior polar (2.6%). In 30% of subjects there was a further anatomical ocular malforma-
tion such as microphthalmia (20%), microcornea (10%) or aberrant iris anatomy (6.67%). A
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previous family history of congenital cataracts was reported in 44.7% of probands, with
a likely autosomal-dominant mode of inheritance. None of the families reported consan-
guinity. One family (Family 27) showed a compound heterozygous inheritance pattern, the
only case in our cohort.
Table 1. Congenital cataracts phenotype characteristics.





Family 01 Lamellar - - - - CRYBB2
Family 02 Nuclear Yes - - - CRYBA4
Family 03 Lamellar - - - Yes CRYGS
Family 04 Nuclear Yes - - Yes CRYAA
Family 05 Nuclear - - - Yes CRYGD
Family 06 Unknown - - - - CRYGD
Family 07 Nuclear Yes - Yes - CRYGC
Family 08 Nuclear - - Yes Yes CRYGC
Family 09 Lamellar - - - Yes CRYBB3
Family 10 Lamellar - - - Yes GJA3
Family 11 Nuclear - - - Yes GJA3
Family 12 Nuclear - Yes - - GJA8
Family 13 Lamellar - - - Yes GJA8
Family 14 Nuclear - - - - GJA8
Family 15 Posteriorsubcapsular - Yes - - GJA8
Family 16 Nuclear Yes - - - GJA8
Family 17 Nuclear - - - Yes LIM2
Family 18 Lamellar - - - Yes LIM2
Family 19 Unknown - - - - LIM2
Family 20 Nuclear Yes - - Yes EPHA2
Family 21 Unknown - - - - EPHA2
Family 22 Nuclear - - - - PAX6
Family 23 Unknown Yes Yes - - PAX6
Family 24 Nuclear - - - Yes MIP
Family 25 Nuclear - - - Yes MIP
Family 26 Nuclear - - - Yes MIP
Family 27 Nuclear - - - Yes HSF4
Family 28 Posteriorsubcapsular - - - Yes PITX3
Family 29 Lamellar - - - - ABCB6
Family 30 Posteriorpolar - - - - TDRD7
Genes 2021, 12, 580 4 of 13
Table 2. Congenital cataracts NGS (next-generation sequencing) results. Het (heterozygosity). ACMG (American College of Medical Genetics and Genomics); VUS: uncertain significance
variant, LP: likely pathogenic and P: pathogenic.
Family
ID Gene Transcript Mutation
ACMG






Family 01 CRYBB2 NM_000496.2 c.562C>A:p.Arg188Ser LP Missense Het Yes De novo Wang Z et al., 2020
Family 02 CRYBA4 NM_001886.3 c.206T>C:p.Leu69Pro P Missense Het Yes De novo Billingsley G et al., 2006
Family 03 CRYGS NM_017541 c.53G>A:p.Gly18Asp P Missense Het Yes Maternal Zhai Y et al., 2017
Family 04 CRYAA NM_000394.4 c.61C>T:p.Arg21Trp P Missense Het Yes Paternal Hansen L et al., 2007
Family 05 CRYGD NM_006891.3 c.T232C:p.Ser78Pro LP Missense Het Yes Maternal Yang G et al., 2016
Family 06 CRYGD NM_006891.3 c.70C>T:p.Pro24Ser P Missense Het No Unknown Plotnikova OV et al., 2007
Family 07 CRYGC NM_020989.4 c.425_432dup:p.Leu145Glyfs * 5 LP Frameshift Het Yes De novo Graw J et al., 2002
Family 08 CRYGC NM_020989.4 c.438delG:p.Arg147Glyfs * 32 LP Frameshift Het Yes Maternal Novel
Family 09 CRYBB3 NM_004076.5 c.531G>T:p.Glu177Asp VUS Missense Het Yes Paternal VCV000900831.1.Variation ID:900831
Family 10 GJA3 NM_021954.4 c.595G>A:p.Glu199Lys LP Missense Het Yes Maternal Novel
Family 11 GJA3 NM_021954.4 c.817_818insATG:p.Tyr272_Ala273insAsp LP In-frame deletion Het Yes Paternal Novel
Family 12 GJA8 NM_005267.5 c.226C>G:p.Arg76Gly LP Missense Het Yes De novo Reis LM et al., 2013
Family 13 GJA8 NM_005267.5 c.64G>A:p.Gly22Ser LP Missense Het Yes Maternal Ye Y et al., 2019
Family 14 GJA8 NM_005267.5 c.565C>G:p.Pro189Ala LP Missense Het No Unknown Novel
Family 15 GJA8 NM_005267.5 c.226C>T:p.Arg76Cys LP Missense Het Yes De novo Reis LM et al., 2013
Family 16 GJA8 NM_005267.5 c.592C>T:p.Arg198Trp P Missense Het Yes De novo Hu S et al., 2010
Family 17 LIM2 NM_030657.4 c.388C>T:p.Arg130Cys LP Missense Het Yes Paternal Berry V et al., 2020
Family 18 LIM2 NM_030657.4 c.388C>T:p.Arg130Cys LP Missense Het Yes Paternal Berry V et al., 2020
Family 19 LIM2 NM_030657.4 c.385C>T:p.Arg129Cys VUS Missense Het Yes Maternal Novel
Family 20 EPHA2 NM_004431.4 c.2826-9G>A LP Splice Het Yes Maternal Zhang T et al., 2009
Family 21 EPHA2 NM_004431.4 c.649G>C:p.Gly217Arg VUS Missense Het Yes Paternal Novel
Family 22 PAX6 NM_001258462.3 c.77G>A:p.Arg26Gln P Missense Het Yes De novo Williamson KA et al., 2020
Family 23 PAX6 NM_001258462.3 c.219G>T:p.Arg73Ser LP Missense Het No Unknown Novel
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Family 24 MIP NM_012064.3 c.676dupC:p.Arg226fs P Frameshift Het Yes Paternal Novel
Family 25 MIP NM_012064.3 c.430T>C:p.Cys144Arg LP Missense Het Yes Maternal Sun W et al., 2020
Family 26 MIP NM_012064.3 c.607-1G>T LP Splice Het Yes De novo Sun W et al., 2020







Allele 2: Paternal Novel
Family 28 PITX3 NM_005029.3 c.640_656delGCCCTGCAGGGCCTGGG:p.Ala214Argfs * 42 LP Frameshift Het Yes Paternal Anand D et al., 2018
Family 29 ABCB6 NM_005689.4 c.1762G>A:p.Gly588Ser VUS Missense Het Yes Maternal Saison C et al., 2013
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Out of the 25 families with a likely pathogenic or pathogenic variant, 16 were de novo
mutations (64%). Of all the identified variants, 30% were mutations in crystallin genes
(one each in genes CRYBB2, CRYBA4, CRYGS, CRYAA and CRYBB3 and two each in genes
CRYGD and CRYGC). All these mutations have already been reported and therefore were
considered as likely pathogenic or pathogenic, except for one case which was interpreted
as a VUS variant. The most frequent phenotype was nuclear cataract, and four families
had another associated anterior chamber malformation: two had microphthalmia and
microcornea (Families 2 and 4) and two others iris hypoplasia (Families 7 and 8).
Mutations in membrane proteins were detected in seven families (two in GJA3 and
five in GJA8). Cataract phenotype was predominantly lamellar in GJA3 and nuclear in GJA8
mutations. Three of the seven families had microphthalmia and/or microcornea (Families
12, 15 and 16). All mutations were classified as likely pathogenic or pathogenic. The third
most frequent mutation affected LIM2 (10%), detected in three different families (Families
17, 18 and 19). Cataract phenotype was nuclear or lamellar, except for one proband with
posterior polar cataract. None of them had any other ocular malformation.
Mutations in MIP were also found in three families (Families 24, 25 and 26). They all
presented with nuclear cataracts with no other ocular malformations and all mutations
were classified as likely pathogenic or pathogenic.
Two probands who had nuclear cataracts plus microphthalmia and microcornea
had a mutation in EPHA2; one of them was considered as likely pathogenic (Family 20).
Mutations in PAX6 were found in two probands, one of them with isolated congenital
cataracts (Family 22) and the other one with associated anterior chamber malformations
(Family 23). Other pathogenic variants found in one proband each, were the following:
HSF4 (Family 27) and PITX3 (Family 28). Other variants found among probands and
classified as VUS (ACMG) were ABCB6 (Family 29) and TDRD7 (Family 30).
3.1. LIM2 Mutations in Two Spanish Families
Mutations in LIM2 were identified in Family 17 (Figure 2a) and Family 18 (Figure 2b).
LIM2 belongs to a group of small integral membrane glycoproteins with a crucial role in
lens biology, cytoskeletal integrity, cell morphology and intercellular communication [26].
The product of LIM2 is a 173-amino-acid membrane protein named MIP20 (alternatively
known as MP17/MP18/MP19), the second most abundant integral membrane protein of
the ocular lens fiber cells of vertebrates [27].
Family 17 includes six affected individuals belonging to three different generations, as
shown in Figure 2a, all of them Caucasian Europeans with no known consanguinity risk
factors. The first generation affected members reported being diagnosed in early infancy;
the second- and third-generation members had been diagnosed in our center during their
first year of life. Nystagmus was present in four of the patients and amblyopia in three of
them. Cataract phenotype was lamellar (four patients) and posterior polar (one patient)
and one of them also suffered from glaucoma. No anterior chamber or posterior pole
malformations were present. NGS was performed, and a LIM2 (c.388C>T) heterozygous
mutation was found in all affected members.
Family 18 includes five affected individuals belonging to three different generations
(Figure 2b) all of them Caucasian Europeans. Affected patients of the second and third
generations had been diagnosed with congenital cataracts during their first year of life. All
patients had been operated promptly after diagnosis. None of them presented nystagmus
or glaucoma. Cataract phenotype was nuclear in all cases and no anterior chamber or
posterior pole malformations were present. NGS was performed, and a LIM2 (c.388 C>T)
heterozygous mutation was found in all affected members.
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hough only 17 congenital cataracts genes were screened [38]. Therefore, it seems that the 
genes affected by pathogenic mutations vary widely and may depend on the race of the 
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designed by Shi et al. and Steele et al. [26,28]. Missense mutations have been associated 
Figure 3. Pedigree of Family 27.
4. Discussion
In the present study, we performed a mutational analysis of Spanish patients diag-
nosed with congenital cataracts implementing the NGS technique. The main reason for
choosing the NGS technique versus whole exome sequencing, was that it is less expensive
while providing an efficient analysi with f wer incidental findings, therefor making it
more suitable for a tertiary hospital. Besides, whole exome sequencing can be performed
in cases in which the NGS technique does not identify mutations. The main advantage of
custom targeted sequencing is the possibility of tailoring it to specific needs, by including a
complete gene sequence, or specific intronic sequences or else UTR regions.
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Mutation detection rate was 49% in the 51 families included in the study; this figure is
slightly lower than reported for similar studies, which ranged from 58% to 70% [29–32].
The detection rate was higher than reported with Sanger sequencing [33]. There was a
high prevalence of VUS variants in our cohort (9.8%). Almost all reported mutations were
autosomal dominant, and approximately 64% of mutations detected were de novo, a lower
rate than previously reported [34,35]. Only one compound heterozygous mutation was
found in our cohort [36].
Crystallins α, β and γ are the predominant proteins of the lens and essential to its
refractive properties [19]. Dominant inheritance has been reported for mutations in all
12 crystallin genes and recessive inheritance has also been reported for mutations in 5 of
them. In crystallin genes, non sense-mediated decay is determinant to whether the mutant
alleles will have recessive or dominant effects. Thus, truncating mutations which appear
in the initial coding sequences of the gene will be affected by non sense-mediated decay
and follow a recessive pattern; whereas mutations in the final exon will be associated
with dominant disease [16]. Mutations in crystallin genes accounted for the majority of
hereditary congenital cataracts in our study (30%), which was an expected result as this is
the most frequent mutation reported up to date. Still, the percentage was lower than in
other published articles. In two studies performed in Chinese families, mutations in the
crystalline genes represented 67% [33] and 40% of the pathogenic mutations detected [37].
Hansen et al. in their study including twenty-eight Danish families found that mutations
in genes encoding crystallins and connexins accounted for 53.5% of pathogenic variants,
although only 17 congenital cataracts genes were screened [38]. Therefore, it seems that
the genes affected by pathogenic mutations vary widely and may depend on the race of
the subjects. Two families (Families 7 and 8) presented a variant in CRYGC. This mutation
changes protein conformation, decreasing its solubility and stability, as well as affecting
its interaction with other crystallins, increasing aggregation. Both families presented with
nuclear congenital cataracts and iris malformations, with microphthalmia in one of them.
Mutations in CRYGC have previously been reported in patients with nuclear or lamellar
cataract, microcornea and microphthalmia [32].
The absence of LIM2 is associated with accelerated breakdown of cytoskeletal proteins
in central lens cells and cataractogenesis, as shown in LIM2-deficient mice models designed
by Shi et al. and Steele et al. [26,28]. Missense mutations have been associated with au-
tosomal recessive cataracts (c.313T>G (p.Phe105Val); c.587G>A (p.Gly154Glu); c.233G>A
(p.Gly78Asp)) [27], and one missense heterozygous mutation causing membranous, lamel-
lar and nuclear cataract (c.388C>T) has recently been reported in European and Asian
populations [29,30]. In our cohort, we identified two families presenting with this variant.
In accordance with previous reports, none of these families’ patients presented any anterior
chamber malformation, and cataract phenotype was diverse (membranous, nuclear, lamel-
lar, posterior polar). This leads us to suspect there might be a higher prevalence of this
mutation than has previously been reported. Further studies investigating LIM2 should
be performed, and this gen should be considered when performing congenital cataracts
genetics study.
Special attention should be devoted to HSF4, the only compound heterozygous variant
found in the studied families. The most common cataract phenotype associated with this
gene is lamellar, and no anterior chamber malformations have been reported so far [39].
Family 27 had risk factors for consanguinity, and presented with nuclear cataract with no
anterior chamber malformations. In the European population, three different autosomal
dominant mutations have been found so far, in Danish [38] and British families [40], show-
ing predominantly a lamellar phenotype. Jiao et al. described a Pakistani consanguineous
family with nuclear cataract and concluded that recessive mutations are mainly located
in hydrophobic repeats (HR-A/B) or downstream of the hydrophobic repeat, in regions
important for a trimeric formation and transcriptional activation of HSF4 [41].
Connexins are crucial for maintaining cell-to-cell communication, which in the lens
occurs mainly via gap junction channels made up of the isoforms GJA1, GJA3 and GJA8.
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Currently, 55 heterozygous variants and 1 homozygous variant have been found in GJA3
as well as 90 heterozygous variants and 1 homozygous variant in GJA8 [16]. The majority
of mutations in GJA8 are dominant missense mutations, and sometimes lead to corneal
abnormalities together with congenital cataracts [16]. Gap junction genes (GJA8 and GJA3)
represent the second most common group of genes affected, as in Shielsa et al. and
Zhang et al. [9,33]. We found seven families presenting this variant, with nuclear and
lamellar cataracts. Among them, three had anterior chamber malformations, which is a
higher prevalence than in other series.
The variant identified in EPHA2 has previously been reported in Mexican [32], Aus-
tralian [42] and British [43] families. Experimental studies have shown that this variant
creates an aberrant splicing signal originating a mutant protein with additional amino acid
residues. Family 20 had nuclear cataracts associated with microphthalmia, as opposed
to the families included in the afore-mentioned reports, which had no anterior chamber
malformation. However, intrafamilial variable expression has been reported and therefore
a complex genotype–phenotype correlation is presumed [32].
The pituitary homeobox (PITX) family of proteins are transcription factors that contain
two domains. Mutations in the PITX family gene PITX3 cause congenital cataract and
anterior segment mesenchymal dysgenesis, such as corneal opacity, microphthalmia and
microcornea [39]. In our cohort, we were able to identify one heterozygous variant in
PITX3 which had previously been described as a homozygous mutation [44]. Family 28
presented with a novel mutation leading to posterior subcapsular cataract without any
other ocular dysgenesis; this phenotype had already been corelated with PITX3 in English
and Chinese families [45,46]. On the other hand, posterior subcapsular cataract due to
PITX3 mutation can also coexist with anterior chamber malformation as shown in five
Belgian families [47].
It should be taken into account that the same mutations may lead to different pheno-
types within the same family. We believe that all affected subjects with a known mutation
should be evaluated, in order to further characterize variable expression by a same mutation
in a given gene.
One limitation of our study is that the NGS panel we used would need to be updated
with the new genes for which previously unknown mutations are described. Another
limitation is the relatively low number of patients included, as well as the lack of mutation
functional analysis. This might explain why our mutation rate is slightly under the mean
value reported so far.
Cases without a molecular diagnosis can be explained because the causative gene
might not be included in the panel design. There may be genes encoding proteins involved
in congenital cataracts of a specific biochemical marker that is currently unknown or not
related to human disease.
5. Materials and Methods
The present study was approved by the Ethics Committee of La Paz University
Hospital of Madrid, and followed the tenets of the Declaration of Helsinki. Informed
consent was obtained from all patients, parents or legal tutors. Our center’s electronic
medical records were used to identify all patients diagnosed with congenital cataracts
between 2005 and 2020. Our center is a major tertiary referral hospital in Spain and patients
with suspected congenital cataracts are referred to us for diagnosis confirmation and
treatment from the whole central region of the country. For genetic diagnosis, patients have
been included in the diagnostic algorithm developed and shown in Figure 4, although
it should be noted that exome studies are still under development in our hospital and
therefore the results of this article are based on the results of the panel.
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The inclusion criteria were as follows: (1) bilateral congenital cataracts, (2) absence
of systemic disease o syndrom potentially related to congenital cataracts. The exclusion
criteria were as foll ws: (1) juv nile developmen of cataract, (2) unilateral cataract, (3) sys-
temic diseas possibly a sociated with congenital cataracts. Demographic d ta including
date of birth, gender, ethnicity, geographical origin of p rents and grandparents, proban
past medical history and deta led family history f ocular disea es were collected. Full
medical records ncluding all ophthalmologica evaluations since diagno i ere reviewe
and the following data was collected: type of cataract (anterior polar, anterior subcapsular,
lamellar, uclear, p sterior subcapsular, posterior pol r, pulverulent) anterior chamber
developmental abnormalities (mic ophthalmia, microcornea, aniridia), vitreous or retinal
abnormalities. A sample of 5 mL of peripheral blood was obtained from all probands
and, whenever possible from both biological parents, and genomic DNA was extracted
from leukocytes.
Genomic DNA was isolated from peripheral blood samples in the preanalytical area
in our institute with commercial Chemagic MSM I (Chemagen, PerkinElmer, EEUU). DNA
quantity was assessed by spectrofluorometer quantification using TECAN M200 Infinite
Pro Microplate Reader. Libraries were prepared using 0.5–1 µg of genomic DNA according
to the SeqCap EZ system.
Mutation screening strategy was based on the use of next-generation sequencing
(NGS) implementing a panel (OFTv2.1) including 39 known non-syndromic congenital
cataracts disease genes as follows: AGK, BFSP1, BFSP2, CHMP4B, CRYAA, CRYAB, CRYBA1,
CRYBA4, CRYBB1, CRYBB2, CRYBB3, CRYGA, CRYGC, CRYGD, CRYGS, EPHA2, EYA1,
FOXE3, FTL, FYCO1, GALK1, GCNT2, GJA3, GJA8, HSF4, LEPREL1, LIM2, MAF, MIP,
MIR184, NHS, PAX6, PITX3, PXDN, SIL1, SLC16A12, SIX6, TDRD7, VIM. The genes were
selected based on https://cat-map.wustl.edu (accessed on 20 January 2021, latest update
August 2020), an online chromosome map and reference database for inherited cataracts.
OFTv2.1 panel was designed with NimbleDesign software (https://design.nimblegen.
com (accessed on 10 January 2020), Roche NimbleGen, Inc., Pleasanton, CA, USA): HG19
NCBI Build 37.1/GRCh37, target bases covered 99.6% and size 370.730 Kb. For each
sample, paired-end libraries were created according to the standard NGS protocols KAPA
HTP Library Preparation Kit for Illumina® platforms, SeqCap EZ Library SR (Roche
NimbleGen, Inc. USA) and NEXTflex-96 Pre Capture Combo Kit (Bioo Scientific, Austin,
TX, USA) for indexing. Captured sample DNA was sequenced on a NextSeq 500 instrument
(Illumina, Inc., San Diego, CA, USA) using a high cartridge v2, according to the standard
operating protocol.
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For the analysis of the results, the INGEMM Clinical Bioinformatics team has designed
a bioinformatics analysis system leading to the identification of point polymorphisms
(SNP), insertions and deletions of small DNA fragments as well as structural variants
of larger size in the capture regions included in the next-generation sequencing panels.
The system comprises a sample pre-processing step, read alignment against a reference
genome, identification and functional annotation of variants and variant filtering. In all
these steps, open tools widely used in the scientific community as well as in-house tools
are employed. Likewise, all phases are designed in a robust manner including statistic
parameters reporting the process status and the convenience of continuing with the analysis.
This allows monitoring the process and appropriate quality controls to release a reliable
report of the afore-mentioned variants. Finally, the system executes security backups
of the raw and processed data. These data are saved in a database with encrypted and
anonymized registries to preserve the confidentiality of the patients.
Bioinformatic analysis was carried out by the Clinical Bioinformatics Unit of INGEMM
centre. Software:trimmomatic-0.32, bowtie2-align version 2.1.0, picard-tools 1.106, sam-
tools Version.0.1.19-44428cd, bedtools v2.18.1, GenomeAnalysisTK version 3.3-0. Data
Bases:dbNSFP version 3.0, dbSNP v138, ClinVar date 20140703, SnpE4.1l, Exac r0.3, SIFT
ensembl 66, Polyphen-2 v2.2.2, MutationAssessor, release 2, FATHMM, v2.3, CADD, v1.3
and dbscSNV1.1.
Variants were analyzed for possible pathogenic clinical significance according to the
2015 American College of Medical Genetics and Genomics (ACMG) guidelines [26], based
on a combination of previous reports in the literature and computational, functional, and
population data. Variants that were classified as pathogenic or likely pathogenic according
to the ACMG guidelines were validated using Sanger sequencing in the proband and
segregation was performed in family members when possible.
6. Conclusions
Although congenital cataracts have a low prevalence, they are a frequent cause of
vision loss in infancy because of limited surgical outcomes, other associated ocular ab-
normalities and the high risk of amblyopia. The causative mutation in non-syndromic
congenital cataracts can often be diagnosed with current genetical analysis techniques. In
the Spanish population, as in most case series reported so far, mutations in crystallin genes
are the leading cause of congenital cataracts. The NGS approach for detecting mutations in
congenital cataracts represents an advance in the diagnosis, allowing a better assessment
of the risk in a subject´s family and improving future reproductive counselling in patients
affected. NGS versus whole exome sequencing might be a better option in most tertiary
hospitals of public health systems.
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